Patients with cancer and concomitant rheumatoid arthritis pose special challenges. Many therapies for rheumatoid arthritis can increase the risk of adverse events during cancer therapy because they are immunosuppressive.
Maria E. Suarez-Almazor, MD, PhD
Advertisement
Articles by Maria E. Suarez-Almazor, MD, PhD
Advertisement
Latest Updated Articles
- Management Considerations in Cancer Patients With Rheumatoid Arthritis
Published: May 16th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
H.R. 2541: Examining Its Legislative Impact on Radiopharmaceutical Practice
2
177Lu-PSMA-I&T/223Ra Display Safety and Feasibility in Metastatic CRPC
3
Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC
4
Trabedersen (OT-101) With Pembrolizumab for Newly Diagnosed PD-L1–Positive Metastatic NSCLC
5
